New York State Common Retirement Fund Portfolio holdings
AUM
$75.2B
1-Year Return
24.38%
This Quarter Return
+0.84%
1 Year Return
+24.38%
3 Year Return
+108.85%
5 Year Return
+192%
10 Year Return
+482.31%
AUM
$93.8B
AUM Growth
-$2.88B
(-3%)
Cap. Flow
-$2.54B
Cap. Flow
% of AUM
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
22.6%
Holding
3,684
New
95
Increased
988
Reduced
2,104
Closed
353
Top Buys
| 1 |
Analog Devices
ADI
|
+$46.3M |
| 2 |
Clarivate
CLVT
|
+$45.1M |
| 3 |
Netflix
NFLX
|
+$35.6M |
| 4 |
DoorDash
DASH
|
+$23M |
| 5 |
iShares Russell 3000 ETF
IWV
|
+$21.3M |
Top Sells
| 1 |
Apple
AAPL
|
+$165M |
| 2 |
Microsoft
MSFT
|
+$156M |
| 3 |
Meta Platforms (Facebook)
META
|
+$92.7M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$86.2M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$77.3M |
Sector Composition
| 1 | Technology | 25.65% |
| 2 | Healthcare | 14.68% |
| 3 | Financials | 14.09% |
| 4 | Consumer Discretionary | 12.02% |
| 5 | Communication Services | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Amalgamated Financial
AMAL
$859M
| $125K | ﹤0.01% |
7,911
-9,177
| -54% | -$145K |
|
3027
Kura Sushi USA
KRUS
$980M
| $125K | ﹤0.01% |
2,869
-7
| -0.2% | -$305 |
|
3028
Zevra Therapeutics
ZVRA
$446M
| $125K | ﹤0.01% |
13,402
-11,098
| -45% | -$104K |
|
|
VOXX
3029
DELISTED
VOXX International Corporation Class A
VOXX
| $125K | ﹤0.01% |
10,897
+2,929
| +37% | +$33.6K |
|
|
QTNT
3030
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $125K | ﹤0.01% |
1,336
+3
| +0.2% | +$281 |
|
3031
Celcuity
CELC
$2.36B
| $124K | ﹤0.01% |
6,879
+79
| +1% | +$1.42K |
|
3032
Integral Ad Science
IAS
$1.42B
| $124K | ﹤0.01% |
+6,000
| New | +$124K |
|
|
DZSI
3033
DELISTED
DZS Inc. Common Stock
DZSI
| $124K | ﹤0.01% |
10,148
-4,776
| -32% | -$58.4K |
|
3034
Lifecore Biomedical
LFCR
$271M
| $123K | ﹤0.01% |
13,346
-7,472
| -36% | -$68.9K |
|
3035
Spruce Power Holding Corp
SPRU
$29.6M
| $123K | ﹤0.01% |
2,504
-1,596
| -39% | -$78.4K |
|
3036
The ONE Group
STKS
$84.5M
| $123K | ﹤0.01% |
11,522
-5,178
| -31% | -$55.3K |
|
3037
Vor Biopharma
VOR
$236M
| $122K | ﹤0.01% |
7,806
-3,486
| -31% | -$54.5K |
|
|
INZY
3038
DELISTED
Inozyme Pharma
INZY
| $121K | ﹤0.01% |
10,453
+1,651
| +19% | +$19.1K |
|
|
FRGI
3039
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $121K | ﹤0.01% |
11,011
-38
| -0.3% | -$418 |
|
3040
Cytek Biosciences
CTKB
$504M
| $120K | ﹤0.01% |
+5,600
| New | +$120K |
|
|
SQSP
3041
DELISTED
Squarespace, Inc.
SQSP
| $120K | ﹤0.01% |
3,106
-14,800
| -83% | -$572K |
|
3042
Evolus
EOLS
$470M
| $119K | ﹤0.01% |
15,553
-12,221
| -44% | -$93.5K |
|
3043
Eterna Therapeutics
ERNA
$10.7M
| $119K | ﹤0.01% |
43
-25
| -37% | -$69.2K |
|
|
TCRR
3044
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $119K | ﹤0.01% |
13,980
-13,747
| -50% | -$117K |
|
3045
Biglari Holdings Class B
BH
$971M
| $118K | ﹤0.01% |
685
-602
| -47% | -$104K |
|
3046
Teva Pharmaceuticals
TEVA
$22.8B
| $118K | ﹤0.01% |
12,093
-13,362
| -52% | -$130K |
|
|
PAMT
3047
PAMT CORP Common Stock
PAMT
$246M
| $118K | ﹤0.01% |
5,244
-4,812
| -48% | -$108K |
|
3048
Vera Bradley
VRA
$58.1M
| $117K | ﹤0.01% |
12,457
-9,702
| -44% | -$91.1K |
|
3049
Adverum Biotechnologies
ADVM
$67.1M
| $115K | ﹤0.01% |
5,277
+15
| +0.3% | +$327 |
|
3050
Barclays
BCS
$72.7B
| $115K | ﹤0.01% |
11,161
| – | – |
|